ArthurPetrieStaddonMD

Oncology • Philadelphia, PA

Associate Clinical Professor of Medicine, University Pennsylvania

Join to view full profile

Dr. Staddon is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Staddon's full profile

Already have an account?

Office
230 W Washington Sq
2nd Floor
Philadelphia, PA 19106
Phone+1 215-829-6088

Fax+1 215-829-6104

Education & Training

University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 1977 - 1980
University of Pennsylvania Health SystemResidency, Internal Medicine, 1972 - 1975
Perelman School of Medicine at the University of PennsylvaniaClass of 1972

Certifications & Licensure

PA State Medical License 1973 - 2024
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2013-2014
Philadelphia Magazine Castle Connolly, 2008, 2011-2014
America's Top Doctors for Cancer Castle Connolly, 2012-2013
Super Doctor SuperDoctors.com
Join now to see all

Clinical Trials

Safety Study of PLX108-01 in Patients With Solid Tumors Start of enrollment: 2009 Oct 01
Completed
Phase 1
Doxorubicin Hydrochloride or Trabectedin in Treating Patients With Previously Untreated Advanced or Metastatic Soft Tissue Sarcoma Start of enrollment: 2011 May 01
Terminated
Phase 2, Phase 3
Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Chondrosarcoma Start of enrollment: 2011 Apr 01
Completed
Phase 2
Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Liposarcoma Start of enrollment: 2012 Mar 01
Completed
Phase 2
Study of Pazopanib in the Treatment of Osteosarcoma Metastatic to the Lung Start of enrollment: 2013 Apr 01
Terminated
Phase 2
Join now to see all

Publications & Presentations

PubMed

365 citations
Structure-Guided Blockade of CSF1R Kinase in Tenosynovial Giant-Cell Tumor.
William D. Tap, Zev A. Wainberg, Stephen P. Anthony, Prabha N. Ibrahim, Chao Zhang
The New England Journal of Medicine. 2015-07-29
96 citations
Randomised phase III trial of trabectedin versus doxorubicin-based chemotherapy as first-line therapy in translocation-related sarcomas
Jean-Yves Blay, Michael G Leahy, Binh Bui Nguyen, Shreyaskumar Patel, Peter Hohenberger
European Journal of Cancer. 2014-04-01
76 citations
Phase 2 study of dasatinib in patients with alveolar soft part sarcoma, chondrosarcoma, chordoma, epithelioid sarcoma, or solitary fibrous tumor.
Scott M. Schuetze, Vanessa Bolejack, Edwin Choy, Kristen N. Ganjoo, Arthur P. Staddon
Cancer. 2017-01-01